botulinum toxin Type A
191622-517
Phase 2 mab completed
Quick answer
botulinum toxin Type A for Benign Prostatic Hyperplasia is a Phase 2 program (mab) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allergan Pharmaceuticals International Limited
- Indication
- Benign Prostatic Hyperplasia
- Phase
- Phase 2
- Modality
- mab
- Status
- completed